SEGMENT AND GEOGRAPHIC INFORMATION (Tables)

3 Months Ended

Mar. 31, 2013

Segment Reporting [Abstract]

Schedule Of Net Sales And Operating Income By Reportable Segment

Net sales and profit by reportable segment for the three months ended March 31, 2013 and 2012 are as follows:

	Three Months Ended March 31,
	2013			2012
	(In thousands)
Segment Net Sales
U.S. Neurosurgery	$	38,996		$	40,183
U.S. Instruments	36,948			37,994
U.S. Extremities	31,361			26,587
U.S. Spine and Other	43,548			44,810
International	45,799			46,611
Total revenues	$	196,652		$	196,185
Segment Profit
U.S. Neurosurgery	$	17,768		$	21,156
U.S. Instruments	10,084			10,067
U.S. Extremities	10,791			9,183
U.S. Spine and Other	13,213			13,533
International	12,878			17,465
Segment profit	64,734			71,404
Amortization	(3,551		)	(4,720)
Corporate and other	(61,227		)	(49,217		)
Operating (loss) income	$	(44	)	$	17,467

Revenues By Market Category

Revenue by major product category consisted of the following:

	Three Months Ended March 31,
	2013		2012
	(In thousands)
Orthopedics	$	90,260	$	86,152
Neurosurgery	63,185		66,057
Instruments	43,207		43,976
Total Revenues	$	196,652	$	196,185

Total Revenue By Major Geographic Area

Total revenue by major geographic area consisted of the following:

	Three Months Ended March 31,
	2013		2012
	(In thousands)
United States	$	150,019	$	148,674
Europe	23,617		23,668
Rest of World	23,016		23,843
Total Revenues	$	196,652	$	196,185